Early results in The Lancet on Oxford coronavirus vaccine clinical made by AstraZeneca suggest the COVID-19 vaccine is safe and induces antibodies and T cell response.
Early results in The Lancet on Oxford coronavirus vaccine clinical made by AstraZeneca suggest the COVID-19 vaccine is safe and induces antibodies and T cell response.
Comments are closed.